[S39] Current Status and Challenges in the Development of Extracellular Vesicle-based Therapeutic Systems

5:43 PM - 5:58 PM JST(8:43 AM - 8:58 AM UTC)

[S39-5] Development of mesenchymal stem cell-derived extracellular vesicle preparations for practical application

○Hayato Kurata¹ (1. ROHTO Pharmaceutical Co., Ltd.)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.